UNICEF and AstraZeneca's Young Health Programme have extended their collaboration in Indonesia for another five years to support prevention of noncommunicable diseases among adolescents and strengthen healthier environments for young people.
Indonesia has around 47 million adolescents aged 10 to 19, representing 17 per cent of the population. According to the 2023 Indonesian Health Survey, overweight affects 12.1 per cent of adolescents aged 13 to 15 and 8.8 per cent of those aged 16 to 18, while obesity affects 4.1 and 3.3 per cent of those age groups respectively.
The next phase will incorporate climate and environmental risks into adolescent health work, including climate-informed prevention in schools and youth-led action on climate and health.
The Indonesia initiative is part of a global UNICEF and AstraZeneca collaboration running from 2026 to 2030, aiming to reach seven million young people across seven countries, support 2,000 schools and community centres and empower 750,000 young leaders.
AstraZeneca has announced more than US$100 million in total investment in its global Young Health Programme between 2010 and 2030, including US$1.3 million for Indonesia during 2026-2030.
